Formulation, Characterization and Solubility Enhancement of Manidipine Solid Dispersions

DOI:

https://doi.org/10.37285/ijpsn.2019.12.2.3

Authors

  • Laxmi Raj A
  • Y. Shravan Kumar

Abstract

The study was aimed to formulate solid dispersions of Manidipine by using different novel carriers like Labrafac PG, Kolliwax RH 40, Soluplus, Kolliwax GMS II, Kolliphor EL and SLS in drug carrier ratio by using solvent evaporation method. The formulations were characterized for physical appearance, solubility and in vitro dissolution studies. The optimized formulation was characterized and Formulation SD13 was found to be optimized one based on the solubility, dissolution and other parameters using Kolliwax GMS II and SLS.  The drug release of the optimized formulation was found to be 99.41±5.38% within 90 min. Powder X-ray diffraction studies performed on solid dispersion showed that Manidipine existed in the amorphous form within the solid dispersion formulation fabricated using the solvent evaporation process. Additionally, scanning electron microscopy studies suggested the conversion of crystalline Manidipine to an amorphous form. Therefore, the solid dispersions using Kolliwax GMS II as hydrophilic carrier in the combination of SLS can be successfully used for improvement of solubility and dissolution of Manidipine.  

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Manidipine, Solvent Evaporation method, Kolliwax, GMS II, Hypertension

Downloads

Published

2019-03-31

How to Cite

1.
A LR, Kumar YS. Formulation, Characterization and Solubility Enhancement of Manidipine Solid Dispersions. Scopus Indexed [Internet]. 2019 Mar. 31 [cited 2024 Nov. 22];12(2):4453-60. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/291

Issue

Section

Research Articles

References

Batra V, Shirolkar VS, Mahaparale PR, Kasture PV and Deshpande AD (2008). Solubility and Dissolution Enhancement of Glipizide by Solid Dispersion Technique. Indian J Pharm Edu Res 42(4): 373-378.
Bhawandeep G, Tejvir K, Sandeep Kumar and Gupta GD (2010). Formulation and evaluation of glimepiride solid dispersion tablets. Asian J Pharm 4 (3): 212-217.
Bolla NM, Chandra S, Koteswara GSN and Devi Uma (2013). Improvement of simvastatin solubility using natural polymers by solid dispersion technique. Inter J of pharm res and biomed analysis 2(2): 2278-2664.
Chaulang G, Patel P, Hardikar S, Kelkar M, Bhosale A and Bhise S (2009). Formulation and Evaluation of Solid Dispersions of Furosemide in Sodium Starch Glycolate. Trop J Pharm Res 8(1): 43-51.
Chiou WL and Rigelman S (1971). Pharmaceutical application of solid dispersion system. J Pharm Sci 60:1281-302.
Dhirendra K, Lewis S and Udupa N (2009). Solid Dispersions a Review. Pak J Pharm Sci 22(2): 234-246.
Dhirendra KL, Udupa N and Atin K (2009). Solid dispersions a review. Pak J Pharm Sci 22: 234-246.
Iimura K and Shima Moto (1993). Efficacy and mode of action of Manidipine a new calcium antagonist. Am Heart J 125: 635-641.
Lakshmi K, Pranav K and Rajesh kaza (2012). Dissolution enhancement of Telmisartan by surface solid dispersion technology. International Journal of Innovative Pharmaceutical Research 3(4): 247-251.
Mandal D, Ojha KP, Nandy CB and Ghosh KL (2010). Effect of Carriers on Solid Dispersions of Simvastatin Physico-Chemical Characterizations and Dissolution Studies. Scholars Research Library Der Pharmacia Lettre 2(4): 47-56.
Morimoto Y and Matsumura (1991). Manidipine hydrochloride Cardio vasc. Drug Rev 9: 201-222.
Poovi G, Uma Maheswari M, Kumar S and Raja Lakshmi AN (2013). Development of Domperidone Solid Dispersion Powders Using Sodium Alginate as Carrier. European Journal of Applied Sciences 5(2): 36-42.
Serajuddin ATM (1999). Solid dispersion of poor water-soluble drugs early promises subsequent problems and recent breakthroughs. J Pharm Sci 88: 1058-1066.
Vara Lakshmi, Siva Ramesh CH, Jyothi I, Jyothi Y, Bharathi G and Chinni Babu P (2015). Formulation and evaluation of solid dispersions of valsartan for dissolution rate enhancement. Journal of Pharmacy Research 9(2): 139-144.